Clinical trial · Interventional
proState Cancer Health Education to pRomote Early sreENing Uptake (SCREEN): A Pilot Randomised Control Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prostate cancer is an issue of significant public health concern. Yet in low- and middle-income countries like Nigeria, men are adversely affected due to factors including poor early prostate cancer screening uptake. Yet a gap remains in addressing this urgent problem. The proposed study seeks to pilot the feasibility and acceptability of a novel co-produced workshop intervention called "proState Cancer awareness education to pRomote Early screENing uptake (SCREEN) with men who are not or partially up to date with their screening. The SCREEN intervention is designed to raise awareness of prostate cancer, its symptoms, implications for late screening, the benefits of early screening, avenues for screening uptake, and also addressing anxiety related to screening uptake. The SCREEN intervention is low-intensity and lasts approximately two hours. The proposed study also aims to pilot and test the instrument to determine its effectiveness and cost-effectiveness, including the mechanism by which the intervention might work.
Conditions
Conditions (6)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anxiety | — | UNRESOLVED | — |
| Health Education | — | UNRESOLVED | — |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
| Screening | — | UNRESOLVED | — |
| Screening and Brief Interventions | — | UNRESOLVED | — |
| Wellbeing | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Control group | Other | — | UNRESOLVED |
| proState Cancer awareness education to pRomote Early screENing uptake | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- proState Cancer awareness education to pRomote Early screENing uptake (SCREEN)
- description
- 2 hour worksop session to foster awareness and encourage screening uptake
- interventionNames
- Behavioral: proState Cancer awareness education to pRomote Early screENing uptake
- type
- ACTIVE_COMPARATOR
- label
- Control group
- description
- The control group will receive intervention as usual. This may be in the form of existing prostate cancer screening information provided in hospitals, media and health centres.
- interventionNames
- Other: Control group
Primary outcomes (1)
- measure
- Service Satisfaction Scale
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Men aged between age 18 years and 79 who are not or partially up to date with prostate cancer * Able to provide full consent for their participation. * Able to speak the English Language. Able to take part in the intervention and are available for the intervention assessment at baseline and end of intervention. Exclusion Criteria: * Less than 18 years * Unable to consent. * Currently undergoing severe mental health treatment. * Unable to speak the English language * not meeting the inclusion criteria.
References
Publications (3)
- BACKGROUNDRawla P. Epidemiology of Prostate Cancer. World J Oncol. 2019 Apr;10(2):63-89. doi: 10.14740/wjon1191. Epub 2019 Apr 20. PMID 31068988
- BACKGROUNDDozie INS, Chukwuocha UM, Innocent DC, Dozie UW, Chukwuemeka PS. A systematic review and meta-analysis of the prevalence and risk factors of prostate cancer in Nigeria. BMC Cancer. 2025 Nov 26;25(1):1932. doi: 10.1186/s12885-025-15358-4. PMID 41299322
- BACKGROUNDAbdus-Salam AA, Jimoh MA, Folasire AM, Ntekim AI, Ojo OT, Ehiedu CG, Yusuf SA, Takure AO, Akinlade BI, Idowu OK, Oladeji AA, Sarimiye FO, Adenipekun AA. Sociodemographic and clinicopathologic characteristics of patients treated with high dose rate prostate brachytherapy in Nigeria. Ecancermedicalscience. 2024 Aug 14;18:1740. doi: 10.3332/ecancer.2024.1740. eCollection 2024. PMID 39421165